{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04708613",
            "orgStudyIdInfo": {
                "id": "Brain Health Initiative"
            },
            "organization": {
                "fullName": "University of Pittsburgh",
                "class": "OTHER"
            },
            "briefTitle": "University of Pittsburgh Brain Health Initiative",
            "officialTitle": "Prevalence of Brain Health Versus Neurodegeneration in Former Professional Football Players",
            "acronym": "BHI",
            "therapeuticArea": [
                "Other"
            ],
            "study": "university-of-pittsburgh-brain-health-initiative"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2019-11-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-01-05",
            "studyFirstSubmitQcDate": "2021-01-13",
            "studyFirstPostDateStruct": {
                "date": "2021-01-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "David Okonkwo, MD, PhD",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "University of Pittsburgh"
            },
            "leadSponsor": {
                "name": "David Okonkwo, MD, PhD",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Football League Scientific Advisory Board",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Avid Radiopharmaceuticals, Inc.",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Harvard University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures."
        },
        "conditionsModule": {
            "conditions": [
                "Traumatic Brain Injury"
            ],
            "keywords": [
                "Brain Health",
                "Football",
                "Contact Sport",
                "Concussion"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Former Professional Football Players",
                    "description": "Former professional football players who played in at least 3 professional seasons, with at least 3 games each season.",
                    "interventionNames": [
                        "Diagnostic Test: Cognitive/Neuropsychological Testing",
                        "Diagnostic Test: Vestibular/Ocular-Motor Testing",
                        "Diagnostic Test: Sleep Evaluation",
                        "Diagnostic Test: MRI, High-Resolution",
                        "Diagnostic Test: Health & Physical Exam",
                        "Diagnostic Test: Physical Function",
                        "Diagnostic Test: Blood Testing and Biomarker Analysis",
                        "Diagnostic Test: Applanation Tonometry",
                        "Diagnostic Test: PET brain imaging",
                        "Drug: [C-11]6-OH-BTA-1",
                        "Drug: [F-18]AV-1451"
                    ]
                },
                {
                    "label": "Control Groups",
                    "description": "Friends and brothers of the Former Professional Football Player group.",
                    "interventionNames": [
                        "Diagnostic Test: Cognitive/Neuropsychological Testing",
                        "Diagnostic Test: Vestibular/Ocular-Motor Testing",
                        "Diagnostic Test: Sleep Evaluation",
                        "Diagnostic Test: MRI, High-Resolution",
                        "Diagnostic Test: Health & Physical Exam",
                        "Diagnostic Test: Physical Function",
                        "Diagnostic Test: Blood Testing and Biomarker Analysis",
                        "Diagnostic Test: Applanation Tonometry",
                        "Diagnostic Test: PET brain imaging",
                        "Drug: [C-11]6-OH-BTA-1",
                        "Drug: [F-18]AV-1451"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Cognitive/Neuropsychological Testing",
                    "description": "Comprehensive testing of cognitive function and brain health.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Vestibular/Ocular-Motor Testing",
                    "description": "A series of tests and questionnaires that asses vestibular function, balance, ocular-motor coordination, and reflexes.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Sleep Evaluation",
                    "description": "A full assessment of sleep health, including insomnia (duration, frequency, daytime consequences) and other sleep disorders such as obstructive sleep apnea. Overnight sleep study is included.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "MRI, High-Resolution",
                    "description": "A high-resolution MRI to provide qualitative and quantitative assessments of brain structure.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Health & Physical Exam",
                    "description": "Participants will undergo an executive history and physical exam of all body systems.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Physical Function",
                    "description": "These assessments will involve a series of tests and questionnaires that focus on physical function.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Blood Testing and Biomarker Analysis",
                    "description": "A blood draw will be performed to measure standard clinical labs as part of a full history and physical, as well as additional analysis of biomarkers indicative of brain health.\n\nAn optional lumbar puncture will be performed and CSF samples (20-30 mL) stored in the NCTC Biorepository until shipment to the CLIA-certified laboratory.\n\nBoth CSF and blood samples will be analyzed for t-tau, p-tau, and A\u03b242 and stored for future testing,",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Applanation Tonometry",
                    "description": "Hearth health is evaluated through testing of arterial stiffness and pulse wave reflections using a high fidelity applanation tonometer.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ],
                    "otherNames": [
                        "Continuous arterial pressure"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "PET brain imaging",
                    "description": "PET imaging of the brain using tau and amyloid ligands.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "[C-11]6-OH-BTA-1",
                    "description": "PET imaging of the brain using an amyloid ligand.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ],
                    "otherNames": [
                        "Pittsburgh Compound B"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "[F-18]AV-1451",
                    "description": "PET imaging of the brain using a tau ligand.",
                    "armGroupLabels": [
                        "Control Groups",
                        "Former Professional Football Players"
                    ],
                    "otherNames": [
                        "[F-18]T807, LY3191748"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rates of Brain Health versus Cognitive Impairment",
                    "description": "The diagnosis of cognitive impairment is based on the ADRC National Alzheimer's Coordinating Center (NACC) criteria for mild cognitive impairment. This criteria is adjudicated following a comprehensive neuropsychological exam, and includes: (1) Self- or informant-reported cognitive complaint, (2) Objective cognitive impairment, (3) Preserved independence in functional abilities, and (4) No dementia.",
                    "timeFrame": "1-week"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Clinical Syndromes of Neurodegeneration",
                    "description": "The determination of trauma-related neurodegeneration will be based on: 1) presence of cognitive deficits, and/or neuromotor manifestations, and/or behavioral/mood-related symptoms; 2) PET scans demonstrating abnormal amyloid and/or tau deposition; 3) quantitative MR evidence of cortical volume loss and/or white matter injury; and 4) elevated CSF tau/A\u03b242 ratio.\n\nThese multiple measures will be combined to arrive at a single overall outcome measure. This will be adjudicated at a blinded Diagnostic Consensus Conference comprised of experts from each field.",
                    "timeFrame": "1-week"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria:\n\nFormer professional football player/exposed group:\n\n1. Professional football retiree aged 29-59\n2. Played a minimum of 3 professional football seasons, with a minimum of 3 games in each season\n3. Fluent in English (translations are not available/validated for most neuropsychological tests)\n\nControl/unexposed group:\n\n1. Age 29-59 male\n2. High school education or beyond\n3. Fluent in English (translations are not available/validated for most neuropsychological tests)\n\nExclusion criteria:\n\nControl/unexposed group:\n\n1. Played organized football beyond high school\n2. History of severe TBI\n3. Current unstable cardiovascular disorder\n\nFor both groups:\n\n1. Prior history of psychosis (such as schizophrenia), or other major neurological disorder that would interfere with testing, in the opinion of the primary investigator.\n2. Contraindication to MR imaging, such as ferrous metal, pacemakers, or concerns about claustrophobia",
            "healthyVolunteers": true,
            "sex": "MALE",
            "genderBased": true,
            "genderDescription": "Females will not be included in the study population. Participants will be prior professional football players, age 29-59, that are eligible for a pension. Control participants will be group-matched for age and gender and therefore females will not be included in the study population.",
            "minimumAge": "29 Years",
            "maximumAge": "59 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "1. Professional Football Players:\n\n   There will be 2 cohorts of former professional football players in this group: (a) random sample, and (b) non-random sample.\n   1. Random-Sample participants\n\n      Recruitment of random-sample former professional football players will be conducted via collaboration with the Football Players Health Study (FPHS) at Harvard University. Subjects for the Brain Health Initiative (BHI) will include a random sample of enrollees in the FPHS who meet basic eligibility for BHI.\n   2. Non-Random participants:\n\n   We will also enroll a non-random cohort of former professional football players that will be comprised of volunteers.\n2. Controls:\n\nThere will be 3 cohorts of unexposed controls in this group: (a) friends of former players, (b) brothers or former players, and (c) general population. Football players will be invited to refer friend(s) and/or brother(s), but it is not required for participation.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kathryn L Edelman, MS",
                    "role": "CONTACT",
                    "phone": "412-624-1077",
                    "email": "dunfeekl@upmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David O Okonkwo, MD, PhD",
                    "affiliation": "University of Pittsburgh Department of Neurological Surgery",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Pittsburgh Department of Neurosurgery",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15213",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kathryn Edelman, MS",
                            "role": "CONTACT",
                            "phone": "412-624-1077",
                            "email": "dunfeekl@upmc.edu"
                        },
                        {
                            "name": "Jane Sharpless, MS",
                            "role": "CONTACT",
                            "phone": "412-648-2176",
                            "email": "sharplessjm@upmc.edu"
                        },
                        {
                            "name": "David O Okonkwo, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "James Mountz, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Michael Collins, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Oscar Lopez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Anthony Kontos, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "14568808",
                    "type": "BACKGROUND",
                    "citation": "Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol. 2003 Oct;60(10):1385-9. doi: 10.1001/archneur.60.10.1385."
                },
                {
                    "pmid": "12904814",
                    "type": "BACKGROUND",
                    "citation": "Petersen RC. Mild cognitive impairment clinical trials. Nat Rev Drug Discov. 2003 Aug;2(8):646-53. doi: 10.1038/nrd1155. No abstract available."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "SAP",
                    "hasProtocol": false,
                    "hasSap": true,
                    "hasIcf": false,
                    "label": "Statistical Analysis Plan",
                    "date": "2018-08-09",
                    "uploadDate": "2023-08-04T11:21",
                    "filename": "SAP_000.pdf",
                    "size": 218093
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001930",
                    "term": "Brain Injuries"
                },
                {
                    "id": "D000070642",
                    "term": "Brain Injuries, Traumatic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000006259",
                    "term": "Craniocerebral Trauma"
                },
                {
                    "id": "D000020196",
                    "term": "Trauma, Nervous System"
                },
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5207",
                    "name": "Brain Injuries",
                    "asFound": "Brain Injury",
                    "relevance": "HIGH"
                },
                {
                    "id": "M628",
                    "name": "Brain Injuries, Traumatic",
                    "asFound": "Traumatic Brain Injury",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12354",
                    "name": "Nerve Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M9349",
                    "name": "Craniocerebral Trauma",
                    "relevance": "LOW"
                },
                {
                    "id": "M22023",
                    "name": "Trauma, Nervous System",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003345",
                    "term": "Corticosterone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6567",
                    "name": "Corticosterone",
                    "asFound": "Somatostatin Receptor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}